Invasive lobular carcinoma (ILC) of the breast is, due to its diffuse infiltrative growth pattern, a diagnostic challenge. Even in retrospect, only up to 80% are visible at mammography. Moreover,…
Although breast magnetic resonance (MR) imaging was initially hindered by the limited availability of coils, protocols, and particularly breast biopsy devices, standardized imaging and specialized equipment necessary to perform high-quality…
Magnetic resonance (MR) imaging identifies cancer not found by clinical examination or other breast imaging studies, but its effect on patient outcomes is controversial. To date, its use has not…
Because of its high negative predictive value in excluding breast cancer, magnetic resonance (MR) imaging plays a role in the evaluation of selected clinical and imaging findings of the breast,…
The MR imaging BI-RADS atlas includes a category for probably benign findings, and many radiologists recommend short-term interval follow-up for breast MR imaging lesions. However, the characteristics of those MR…
Neoadjuvant chemotherapy is now widely used in the management of locally advanced breast cancer (LABC). Early initiation of systemic therapy can improve overall and disease-free survival for patients with LABC…
The technical requirements for magnetic resonance imaging (MRI) of the breasts are challenging because high temporal and high spatial resolution are necessary. This article describes the necessary equipment and pulse…
Breast cancer is the most common cancer in women. One in 8 women develops breast cancer and approximately 30% of all affected women die of the disease. By performing a…
Preoperative breast imaging evaluation can contribute useful clinical information to the management of the patient with known breast cancer. Breast magnetic resonance imaging (MRI) has been used as part of…
Ductal carcinoma in situ (DCIS) now accounts for well over 20% of cancers diagnosed in mammography screening programs. This article reviews the biology of DCIS and the unique kinetic and…
